PLOD2 and head and neck squamous cell carcinoma: HNSCC patients with an increased risk score showed significantly upregulated expression of high-risk type mRNA (PPIB, BASP1 and PLOD2); in contrast, the expression of protective type mRNA (WIPF1) was down-regulated.